Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can mexidol help glaucoma patients see better?

NCT ID NCT06903156

Completed Disease control Sponsor: Pharmasoft Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested different doses of the drug Mexidol in 102 adults with moderate to advanced open-angle glaucoma. The goal was to see if the drug could improve vision compared to a placebo. Participants took the drug or placebo in a sequence over several months, and their vision was measured using standard eye tests.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY OPEN ANGLE GLAUCOMA (POAG) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glaucoma inborn mitochondrial metabolism disorder open-angle glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PRIMARY OPEN ANGLE GLAUCOMA (POAG)

Contacts and locations

Locations

  • Budgetary healthcare institution of the Omsk region "V.P. Vyhodtsev Clinical Ophthalmological Hospital"

    Omsk, 644024, Russia

  • Federal State Autonomous Institution "Intersectoral Scientific and Technical Complex "Eye Microsurgery" named after Academician S.N. Fedorov" of the Ministry of Health of the RF

    Moscow, 127486, Russia

  • Federal State Budgetary Educational Institution of Higher Education "Moscow State Medical and Dental Institute named after A.I. Evdokimov" of the Ministry of Health of the RF

    Moscow, 127473, Russia

  • Kirov Regional State Budgetary Healthcare Institution "Kirov Clinical Ophthalmological Hospital"

    Kirov, 610047, Russia

  • Private healthcare institution "Clinical hospital "RZhD-Medicine" of the city of Saratov"

    Saratov, 410004, Russia

  • Saint Petersburg State Budgetary Healthcare Institution "State Hospital No. 40 of the Kurortny District"

    Saint Petersburg, 197706, Russia

  • State Budgetary Institution of Healthcare of the Yaroslavl Region "Clinical Hospital No. 2"

    Yaroslavl, 150030, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.